A Conservative MP is making an unexpected pitch to overhaul Canada's drug laws — one that would legalize prescribing psychedelics like psilocybin, the active compound in magic mushrooms.
Conservative MP Corey Tochor introduced the legislation on Tuesday, arguing that researchers and patients alike say these substances can effectively treat certain mental health disorders. It's a notable move from a party not typically associated with loosening drug restrictions.
What the bill proposes
The legislation aims to revamp Canada's existing drug laws to allow doctors to prescribe psychedelics such as psilocybin. Right now, access to these substances is tightly restricted, and patients who want to use them therapeutically often have to navigate a complicated patchwork of special exemptions and clinical trials.
Tochor's bill would carve out a clearer legal pathway for prescribing, putting these compounds within reach for patients under medical supervision rather than leaving them in a legal grey zone.
The case for psychedelic therapy
The push is rooted in a growing body of research. Over the past several years, studies have explored psilocybin and other psychedelics as potential treatments for conditions like treatment-resistant depression, PTSD, and end-of-life anxiety.
For patients who have exhausted conventional options, advocates say these therapies can be life-changing. Many have spoken publicly about the difference psychedelic-assisted treatment has made when standard medications and therapy fell short. Supporters of the bill point to those experiences — alongside the science — as the reason Canada's laws need to catch up.
Why it matters
Drug policy reform is rarely a tidy political story, and this one is no exception. A Conservative MP championing the legalization of psychedelics cuts against the usual partisan lines, signalling that support for medical access may be broader than the typical debate suggests.
Whether the bill advances is another question. Private member's bills face long odds of becoming law, and any change to Canada's drug framework would likely spark debate over regulation, safety, and how prescribing would actually work in practice.
Still, the introduction of the legislation puts psychedelic therapy squarely on Parliament's radar. For the researchers and patients who have spent years pushing for legal access, even a debate on the floor of the House of Commons represents progress.
What comes next
For now, the bill is just the opening move. It will need to clear the usual legislative hurdles — readings, committee study, and votes — before anything changes for patients or doctors.
But the conversation it sparks could shape how Canada approaches mental health treatment in the years ahead. As more evidence accumulates on the therapeutic potential of psychedelics, pressure to modernize the country's drug laws is unlikely to fade.
Source: CBC Politics
